Task: Answer Verification
Input (English): Question: Does generalizability of trial result to elderly Medicare patients with advanced solid tumors ( Alliance 70802 )?
Answer: Results of clinical trials for advanced pancreatic cancer and lung cancers tended to correctly estimate survival for Medicare patients aged 65 to 74 years, but to overestimate survival for older Medicare patients by six to eight weeks. These estimates of Medicare patients' survival may aid subsequent patients and their oncologists in treatment decision-making.
Output (English): yes